Oligonucleótidos modificados para controlar los genes

Entre las futuras terapias con más potencial se encuentran las basadas en ARN interferente, donde la expresión de un determinado gen es inhibido completamente.

Enlace a texto completo en medio: Madri+d

Institutes News

• trending_flatIrene de Bustamante recoge el Premio Custodio y Llamas AIH-GE a la Trayectoria Profesional en Hidrogeología

• trending_flatCulinary medicine: a key tool against obesity, diabetes, cardiovascular disease and certain types of cancer

• trending_flatDefensa tesis doctoral: “MOF-based nanocomposites for combined imaging and therapy”

• trending_flatAdditive Manufacturing researchers from across Europe gather at IMDEA Materials for the AM2C3 Summer School

• trending_flatDr. Liangxuan Wang receives the Friedrich-Förster Award for young scientists in the field of physics or physical chemistry, granted by the University of Tübingen.

• trending_flatPRIME-6G launches to build the next generation of connected factories

• trending_flatIntersecting Dense Automata: Constructions, Complexity and Certificates

More Institutes

Latest Events

• trending_flatMadrid es Ciencia Fair 2026: Science, laughter and excitement with IMDEA

• trending_flatIMDEA Institutes at the Madrid es Ciencia Fair 2026: Is it really not science fiction?

• trending_flatTransforming Innovation Together – IMDEA at Transfiere 2026

See Events